Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 79,300 | 40,700 | 45,100 | 31,200 | 1,700 |
| Depreciation Amortization | 56,200 | 41,800 | 27,800 | 13,600 | 55,700 |
| Income taxes - deferred | -13,800 | -4,300 | 2,300 | 3,600 | 800 |
| Accounts receivable | -15,200 | -21,900 | -24,700 | -20,800 | 9,600 |
| Other Working Capital | -2,400 | -7,200 | -33,200 | -31,800 | 96,100 |
| Other Operating Activity | 32,700 | 43,400 | 36,200 | 25,100 | 16,700 |
| Operating Cash Flow | $136,800 | $92,500 | $53,500 | $20,900 | $180,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23,900 | -25,200 | -14,400 | -5,600 | -27,400 |
| Net Acquisitions | N/A | N/A | N/A | 9,200 | -137,700 |
| Purchase Of Investment | -1,500 | -800 | -700 | -100 | -1,000 |
| Sale Of Investment | N/A | 9,200 | 9,200 | N/A | N/A |
| Purchase Sale Intangibles | -2,500 | -2,100 | -900 | -700 | -11,000 |
| Other Investing Activity | -1,800 | -1,600 | -900 | -700 | -11,000 |
| Investing Cash Flow | $-27,200 | $-18,400 | $-6,800 | $2,800 | $-177,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 337,300 | 217,800 | 99,600 | 64,600 | 285,700 |
| Debt Repayment | -278,200 | -226,900 | -93,800 | -53,800 | -278,600 |
| Common Stock Issued | 26,200 | 22,100 | 14,700 | 6,600 | 30,500 |
| Common Stock Repurchased | -53,500 | -36,400 | -16,000 | -12,500 | -59,100 |
| Other Financing Activity | -2,800 | -2,800 | 3,600 | -2,800 | 1,000 |
| Financing Cash Flow | $29,000 | $-26,200 | $8,100 | $2,100 | $-20,500 |
| Exchange Rate Effect | -8,900 | -8,800 | -7,600 | -2,100 | 4,800 |
| Beginning Cash Position | 48,900 | 48,900 | 48,900 | 48,900 | 61,100 |
| End Cash Position | 178,600 | 88,000 | 96,100 | 72,600 | 48,900 |
| Net Cash Flow | $129,700 | $39,100 | $47,200 | $23,700 | $-12,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 136,800 | 92,500 | 53,500 | 20,900 | 180,600 |
| Capital Expenditure | -48,500 | -26,600 | -15,800 | -6,000 | -42,500 |
| Free Cash Flow | 88,300 | 65,900 | 37,700 | 14,900 | 138,100 |